200
Views
9
CrossRef citations to date
0
Altmetric
Eco/Toxicology

Acrylamide and its metabolite glycidamide can affect antioxidant defenses and steroidogenesis in Leydig and Sertoli cells

ORCID Icon
Pages 247-257 | Received 10 Aug 2017, Accepted 11 Jun 2018, Published online: 14 Aug 2018
 

Abstract

Acrylamide, which is commonly used in various industries, may also form in food products cooked in high temperatures. Glycidamide, the ultimate genotoxic metabolite of acrylamide, is generated within cells through CYP4502E1-mediated epoxidation. Recent studies have shown that acrylamide and/or glycidamide may cause infertility by disrupting spermatogenesis, decreasing germ cell production and sperm fertilization ability due to their toxic effects on the male reproductive system. This study aimed to determine some direct effects of acrylamide and glycidamide on antioxidant defenses and on steroidogenic enzymes of Leydig and Sertoli cells. For this purpose, mouse Leydig and Sertoli cells were exposed to acrylamide (0.01 or 1 mmol/L) or to glycidamide (0.001 or 0.5 mmol/L) for 24 h. Following the exposure, antioxidant enzyme activities (catalase, superoxide dismutase, glutathione peroxidase and γ-glutamyl transpeptidase), cellular antioxidant levels (glutathione) and steroidogenic enzyme activities (3β-hydroxysteroid dehydrogenase and 17β-hydroxysteroid dehydrogenase) were calculated. It was shown that acrylamide and glycidamide may cause inhibition of antioxidant and steroidogenic enzymes in Leydig and Sertoli cells. In conclusion, acrylamide and glycidamide may alter testicular function, thereby disrupting male reproduction.

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This study was supported by Department of Scientific Research Projects, Istanbul University (Project Number: 45799).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.